DJAM:F:F-Lyxor UCITS ETF Dow Jones Industrial Average (EUR)

ETF | Others |

Last Closing

USD 416.3

Change

0.00 (0.00)%

Market Cap

N/A

Volume

7.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-04 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

-0.13 (-0.47%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

-0.22 (-0.41%)

USD 116.19B
SXR8:F iShares Core S&P 500 UCITS ETF..

+0.38 (+0.06%)

USD 109.51B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

-0.17 (-0.30%)

USD 98.97B
XDNY:F Xtrackers MSCI Japan ESG Scree..

-0.08 (-0.51%)

USD 63.27B
SXRZ:F iShares VII PLC - iShares Nikk..

-1.75 (-0.71%)

USD 52.42B
VUSA:F Vanguard Funds Public Limited ..

-0.29 (-0.26%)

USD 51.63B
VUAA:F Vanguard S&P 500 UCITS Acc

+0.20 (+0.18%)

USD 51.63B
XJSE:F Xtrackers II - Japan Governmen..

-0.10 (-1.26%)

USD 38.52B
0ZC:F Zscaler Inc

+3.64 (+2.07%)

USD 37.92B

ETFs Containing DJAM:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 1.26% 66% D+ 49% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 1.26% 65% D 49% F
Trailing 12 Months  
Capital Gain 21.05% 76% C+ 70% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 21.05% 73% C 61% D-
Trailing 5 Years  
Capital Gain 63.10% 82% B 76% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 63.10% 82% B 59% D-
Average Annual (5 Year Horizon)  
Capital Gain 12.95% 79% B- 71% C-
Dividend Return 12.95% 77% C+ 64% D
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 11.68% 59% D- 87% B+
Risk Adjusted Return 110.87% 97% N/A 97% N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike